Dr. Li Gan, a neuroscientist internationally acclaimed for her research into neurodegenerative diseases, has been appointed director of the Helen and Robert Appel Alzheimer’s Disease Research Institute at Weill Cornell Medicine, effective July 1.
The Appel Institute was established in 2006 with a $15 million gift from Helen and Robert Appel, vice chair of the Weill Cornell Medicine Board of Overseers. An integral part of the Feil Family Brain and Mind Research Institute (BMRI) and headquartered in the Belfer Research Building, the Appel Institute is dedicated to understanding the molecular, cellular and genetic underpinnings of Alzheimer’s disease and related degenerative neurological disorders for the benefit of patient care.